Literature DB >> 26341183

Gender Disparities in Outcomes and Resource Utilization for Acute Pulmonary Embolism Hospitalizations in the United States.

Shikhar Agarwal1, Donald Clark1, Karan Sud1, Wael A Jaber1, Leslie Cho1, Venu Menon2.   

Abstract

Current data regarding gender disparities in outcomes after acute pulmonary embolism (PE) are limited and controversial. We sought to assess the gender-specific rates and trends in treatment, outcomes, and complications after acute PE. We used the 2003 to 2011 Nationwide Inpatient Sample database for this analysis. All hospital admissions with a principal diagnosis of acute PE were identified using the International Classification of Diseases, Ninth Edition, codes. Inhospital mortality and discharge to nursing facility were co-primary outcomes of our study. Secondary outcomes included shock, transfusion of blood products, utilization of thrombolysis, inferior vena cava filter placement, and cost of hospitalization. Over a 9-year period, a total of 276,484 discharges with acute PE were identified. Compared with men, there was significantly higher inhospital mortality in women admitted with acute PE (odds ratio [OR] 1.09, 95% confidence interval [CI] 1.03 to 1.15). In addition, there was a significantly higher need for discharge to nursing facility among women compared with men (OR 1.30, 95% CI 1.27 to 1.34). Besides this, women experienced a higher need for transfusion (OR 1.38, 95% CI 1.33 to 1.44) and occurrence of shock (OR 1.10, 95% CI 1.01 to 1.18) during hospitalization. Furthermore, there was a significantly lower utilization of vena cava filters (OR 0.86, 95% CI 0.84 to 0.89) in women compared with men. Among patients in shock who were eligible for thrombolysis (age <75 years, no previous stroke, no bleeding on presentation, and not pregnant), the utilization of thrombolysis was similar between men and women (OR 1.19, 95% CI 0.93 to 1.53). Lastly, the cost of hospitalization after acute PE was significantly higher in men than women (adjusted mean difference $425, 95% CI $304 to $546). In conclusion, among patients admitted with acute PE, women tend to have more adverse outcomes and higher incidence of complications compared with men.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26341183     DOI: 10.1016/j.amjcard.2015.07.048

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  16 in total

1.  Sex disparities in hospitalization and mortality rates for venous thromboembolism.

Authors:  Sola Mansour; Ghazi Alotaibi; Cynthia Wu; Khalid Alsaleh; Michael Sean McMurtry
Journal:  J Thromb Thrombolysis       Date:  2017-08       Impact factor: 2.300

2.  Sex differences in utilization and outcomes of catheter-directed thrombolysis in patients with proximal lower extremity deep venous thrombosis - Insights from the Nationwide Inpatient Sample.

Authors:  Vladimir Lakhter; Chad J Zack; Yevgeniy Brailovsky; Saurav Chatterjee; Vikas Aggarwal; Koneti A Rao; Deborah Crabbe; Huaqing Zhao; Eric Choi; Raghu Kolluri; Riyaz Bashir
Journal:  Vasc Med       Date:  2017-03-17       Impact factor: 3.239

3.  Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The CVRN VTE Study.

Authors:  Margaret C Fang; Dongjie Fan; Sue Hee Sung; Daniel M Witt; John R Schmelzer; Marc S Williams; Steven H Yale; Christine Baumgartner; Alan S Go
Journal:  Am J Med       Date:  2019-06-25       Impact factor: 4.965

Review 4.  Acute Pulmonary Embolism–Its Diagnosis and Treatment From a Multidisciplinary Viewpoint.

Authors:  Hannah C Kulka; Andreas Zeller; Jürgen Fornaro; Walter A Wuillemin; Stavros Konstantinides; Michael Christ
Journal:  Dtsch Arztebl Int       Date:  2021-09-17       Impact factor: 5.594

5.  Clinical Significance of ST Elevation in Lead aVR in Acute Pulmonary Embolism.

Authors:  Leili Pourafkari; Samad Ghaffari; Arezou Tajlil; Fariborz Akbarzadeh; Farin Jamali; Nader D Nader
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-05-25       Impact factor: 1.468

6.  Variable predictors of acute pulmonary embolism recurrence with duration of follow-up.

Authors:  Yi-Lan Yang; Ping Yuan; Chuan-Yu Wang; Bigyan Pudasaini; Yuan Li; Yan-Zhe Yu; Qin-Hua Zhao; Lan Wang; Su-Gang Gong; Rong Jiang; Wen-Hui Wu; Jing He; Jian Guo; Ci-Jun Luo; Hong-Ling Qiu; Chang Chen; Jin-Ling Li; Jin-Ming Liu
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 2.895

7.  Type 2 Diabetes Is a Risk Factor for Suffering and for in-Hospital Mortality with Pulmonary Embolism. A Population-Based Study in Spain (2016-2018).

Authors:  Rodrigo Jiménez-García; Romana Albaladejo-Vicente; Valentin Hernandez-Barrera; Rosa Villanueva-Orbaiz; David Carabantes-Alarcon; Javier de-Miguel-Diez; José Javier Zamorano-Leon; Ana Lopez-de-Andres
Journal:  Int J Environ Res Public Health       Date:  2020-11-11       Impact factor: 3.390

8.  American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism.

Authors:  Thomas L Ortel; Ignacio Neumann; Walter Ageno; Rebecca Beyth; Nathan P Clark; Adam Cuker; Barbara A Hutten; Michael R Jaff; Veena Manja; Sam Schulman; Caitlin Thurston; Suresh Vedantham; Peter Verhamme; Daniel M Witt; Ivan D Florez; Ariel Izcovich; Robby Nieuwlaat; Stephanie Ross; Holger J Schünemann; Wojtek Wiercioch; Yuan Zhang; Yuqing Zhang
Journal:  Blood Adv       Date:  2020-10-13

9.  Sex differences in the characteristics and short-term prognosis of patients presenting with acute symptomatic pulmonary embolism.

Authors:  Deisy Barrios; Raquel Morillo; Ina Guerassimova; Esther Barbero; Héctor Escobar-Morreale; Alexander T Cohen; Cecilia Becattini; Victor Tapson; Roger Yusen; David Jimenez
Journal:  PLoS One       Date:  2017-11-06       Impact factor: 3.240

10.  The diagnostic value of D-dimer with simplified Geneva score (SGS) pre-test in the diagnosis of pulmonary embolism (PE).

Authors:  Zhihui Fu; Xibin Zhuang; Yueming He; Hong Huang; Weifeng Guo
Journal:  J Cardiothorac Surg       Date:  2020-07-20       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.